A Health Affairs blog post by Jen Kates examines the future of development assistance for global health.
Global Health PolicySee more about Global Health Policy
- state & global data
- view as grid
- view as list
In recent years, the U.S. government has paid increasing attention to the health and human rights of lesbian, gay, bisexual and transgender (LGBT) individuals around the world, utilizing both multilateral and bilateral channels. Still, however, many LGBT individuals continue to face stigma, discrimination, and violence, both within and outside of the health sector, which compromise their ability to access needed health services and can adversely affect health status. Moreover, in many countries, the barriers faced by LGBT individuals include discriminatory laws and policies. To explore opportunities and challenges facing the U.S. government in this arena, the Kaiser Family Foundation convened two roundtable discussions of high-level experts working on global LGBT health and rights as well as those working more broadly on global health. This issue brief summarizes the main points of discussion raised by roundtable participants, focusing on opportunities, challenges, and potential next steps for the U.S. government to consider in addressing the health needs of LGBT individuals around the world. It also provides an overview of global LGBT health issues, and reviews U.S. government efforts to address global LGBT health to date.
The Kaiser Family Foundation convened a public forum to take stock of the global health challenge presented by TB, to examine the limitations and challenges of current treatment options, their limitations and challenges, and to discuss the search for new and better TB drugs and other tools. The event began with a screening of a short segment of a new FRONTLINE television documentary, TB Silent Killer, which focuses on the Southern African nation of Swaziland, the country with the world’s highest incidence of TB, and delivers a portrait of the people living at the pandemic’s epicenter.
This budget analysis reviews U.S. funding for global health programs included in the fiscal year 2015 Budget Request released on March 4, 2014. It examines funding by program area as well as trends over time.
This report finds that donor governments provided US$1.3 billion in bilateral funding for family planning programs in low and middle income countries in 2013 – a 19 percent increase from 2012. Donor governments also gave an additional $454 million in core contributions to the United Nations Population Fund (UNFPA), the primary multilateral organization addressing family planning. Funding has risen since the London Summit on Family Planning in 2012, although most of the increase was driven by a small number of donors.
Analysis Finds Donor Government International Funding for Family Planning Increased By 19 Percent From 2012
A new Kaiser Family Foundation report finds that donor governments provided US$1.3 billion in bilateral funding for family planning programs in low- and middle-income countries in 2013 – a 19 percent increase from 2012. Donor governments also gave an additional $454 million in core contributions to the United Nations Population Fund…
This Policy Insight take a deeper look at several key measures of the impact of the current Ebola epidemic in West Africa, including estimates of current cases, prevalence and death rates, as well as a consideration of the future projections of Ebola’s burden in the months to come.
In the latest post in the Policy Insights series, Jen Kates and Josh Michaud take a look at several key measures of the Ebola epidemic’s impact and assess future projections of Ebola’s burden in the months to come. Previous columns in the Policy Insights series are also available kff.org.
This fact sheet examines the U.S. government’s role in international family planning and reproductive health worldwide, including the history of U.S. government involvement, current programs and funding, and key issues.
This fact sheet provides a snapshot of global non-communicable disease efforts and examines the U.S. government’s role in addressing non-communicable diseases worldwide, including current activities, funding, and key issues.